Our extensive work in rodent models of RP clearly validated that intravitreal injections of recombinant TIMP-1 protein and other MMP-9 inhibitors slow down rod photoreceptor cell death [12–14]. This evidence concerns the gene MMP9 and retinitis pigmentosa 1.